| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| etretinate | retinoic acid receptor alpha | small molecule | NA | drugbank , DGIDB | Psoriasis[MeSHID:D011565] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Actinic keratosis[MeSHID:D055623] Keratosis[MeSHID:D007642] |
1.76 | withdrawn | agonist |
| etretinate | retinoic acid receptor beta | small molecule | NA | drugbank , DGIDB | Psoriasis[MeSHID:D011565] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Actinic keratosis[MeSHID:D055623] Keratosis[MeSHID:D007642] |
1.82 | withdrawn | agonist |
| etretinate | retinoic acid receptor gamma | small molecule | NA | drugbank , DGIDB | Psoriasis[MeSHID:D011565] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Actinic keratosis[MeSHID:D055623] Keratosis[MeSHID:D007642] |
2.14 | withdrawn | agonist |
| etretinate | retinoic acid receptor rxr-alpha | small molecule | NA | drugbank , DGIDB | Psoriasis[MeSHID:D011565] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Actinic keratosis[MeSHID:D055623] Keratosis[MeSHID:D007642] |
0.5 | withdrawn | agonist |
| etretinate | retinoic acid receptor rxr-beta | small molecule | NA | drugbank , DGIDB | Psoriasis[MeSHID:D011565] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Actinic keratosis[MeSHID:D055623] Keratosis[MeSHID:D007642] |
3.03 | withdrawn | agonist |
| etretinate | retinoic acid receptor rxr-gamma | small molecule | NA | drugbank , DGIDB | Psoriasis[MeSHID:D011565] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Actinic keratosis[MeSHID:D055623] Keratosis[MeSHID:D007642] |
4.55 | withdrawn | agonist |
| click here to return to the previous page | ||||||||